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similarity in their N-terminal regions. These highly con-Jerard Hurwitz,‖ Mike O’Donnell,‡§
served regions are by themselves sufficient to inhibitand John Kuriyan*†
cyclin–cdks that function at major transition points in*Laboratory of Molecular Biophysics
the cell cycle. The structure of the N-terminal region of†Howard Hughes Medical Institute
p27Kip1 bound to the cyclin A–Cdk2 complex has beenThe Rockefeller University
reported recently (Russo et al., 1996). The inhibitor mole-New York, New York 10021
cule is poorly structured when not bound to cyclin–cdk.‡Department of Microbiology
The cyclin A–Cdk2 complex acts as a template or scaf-§Howard Hughes Medical Institute
folding that induces an extended structure in the 69Cornell Medical College
residues at the N-terminus of p27Kip1, which binds tightlyNew York, New York 10021
across the cyclin–cdk interface and the ATP-binding‖Program in Molecular Biology
lobe of the kinase. Given the similarity in their N-terminalMemorial Sloan-Kettering Cancer Center
regions, this structure of the p27Kip1–cyclin A–Cdk2 com-1275 York Avenue
plex provides a good model for understanding the inter-New York, New York 10021
actions of p21 with cyclin–cdk complexes (Russo et al.,
1996).
However, in contrast to p27Kip1 or p57Kip2, p21 is alsoSummary
able directly to inhibit DNA replication by binding tightly
to and blocking the action of the DNA polymerase pro-The crystal structure of the human DNA polymerase
cessivity factor PCNA (proliferating cell nuclear antigen;d processivity factor PCNA (proliferating cell nuclear
Flores-Rozas et al., 1994; Waga et al., 1994). PCNA isantigen) complexed with a 22 residue peptide derived
a DNA-tracking protein that is required for the rapid andfrom the C-terminus of the cell-cycle checkpoint pro-
processive replication of DNA by the polymerases dtein p21WAF1/CIP1 has been determined at2.6 A˚ resolution.
and e because it forms a sliding clamp that tethers thep21 binds to PCNA in a 1:1 stoichiometry withan exten-
polymerase to DNA during strandsynthesis (Kelman andsive array of interactions that include the formation of
O’Donnell, 1995; Krishna et al., 1994). The C-terminala b sheet with the interdomain connector loop of
region of p21WAF1/CIP1 is distinct from that in p27Kip1 andPCNA. An intact trimeric ring is maintained in the
p57Kip2 and contains a PCNA–binding sequence (War-structure of the p21–PCNA complex, with a central
brick et al., 1995). The overexpression in mammalianhole available for DNA interaction. The ability of p21
cells of C-terminal fragments containing this region isto inhibit the action of PCNA is therefore likely to be
sufficient to arrest DNA replication (Chen et al., 1995b;due to its masking of elements on PCNA that are re-
Goubin and Ducommun, 1995; Luo et al., 1995; Warbrickquired for the binding of other components of the poly-
et al., 1995). Biochemical experiments have shown thatmerase assembly.
this inhibition is due to a direct interaction between p21
and PCNA and that the inhibition can be relieved by
Introduction excess PCNA (Flores-Rozas et al., 1994; Shivji et al.,
1994; Waga et al., 1994). The inhibition of cyclin–cdk by
The arrest of DNA replication in response to the detec- p21 appears to be more critical for the regulation of
tion of DNA damage is a fundamental mechanism by the G1-to-S transition, and the particular role of the
which the cell minimizes the potential transmission of p21–PCNA interaction remains to be determined (Na-
lethal mutations. One mediator of this response is the kanishi et al., 1995). The molar ratio of p21 to PCNA in
protein p21WAF1/CIP1 (hereafter referred to as p21), an inhib- normal human diploid fibroblasts has been shown to be
itor of the cyclin-dependent protein kinases (cdks) that close to 1:1, suggesting that a direct inhibitory interac-
control the initiation of the S phase of the cell cycle and tion between these two proteins is likely to be biologi-
concomitant DNA replication (El-Deiry et al., 1993; Gu cally relevant (Li et al., 1996). PCNA is also required for
et al., 1993; Harper et al., 1993; Noda et al., 1994; for nucleotide excision repair (Nichols and Sancar, 1992;
review see Peter and Herskowitz, 1994). An elevation of Shivji et al., 1992), but the precise effect of p21 on this
nuclear levels of the tumor suppressor protein p53 oc- process also needs further clarification (Li et al., 1994,
curs upon detection of DNA damage. This stimulates 1996; Pan et al., 1995; Shivji et al., 1994).
transcription of p21 as part of a p53 signaling pathway The PCNA–binding functionality of p21 appears to
in which the cessation of DNA replication is coupled reside entirely in the C-terminal 22 residues of the pro-
to stalling of cellular mitosis (Waldman et al., 1996). In tein, which also suffice to block PCNA–mediated DNA
addition, the levels of p21 also respond tocertain stimuli, replication directly (Chen et al., 1996; Pan et al., 1995;
such as growth factors, in a p53-independent manner. Warbrick et al., 1995). A peptide corresponding to these
p21 is a member of a family of cdk-inhibitory proteins, 22 residues binds to human PCNA with high affinity,
including p27Kip1 (Polyak et al., 1994), p57Kip2 (Lee et al., comparable with that of the intact p21 protein (Kd of
approximately 2.5 nM, as measured by biosensor analy-
sis) and efficiently inhibits DNA synthesis in vitro (Gibbs# Present address: Department of Molecular Biology and Genetics,
Johns Hopkins University, Baltimore, Maryland 21205. et al., submitted; Pan et al., 1995). The finding that a
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relatively short peptide can capture the binding and (139GRKRRQTSMTDFYHSKRRLIFS160, p21 sequence
numbering), 17 are modeled unambiguously. The firstinhibitory capacity of the p21 protein is particularly intri-
guing since the architecture of PCNA is not immediately five residues at the peptide N-terminus are not clearly
visible in the electron density maps and are located insuggestive of a peptide-binding function. The crystal
structure of Saccharomyces cerevisiae PCNA (scPCNA) the vicinity of the C-terminal region of PCNA, which
is also disordered. A set of two short loops near thehas been determined (Krishna et al., 1994), revealing a
ring-shaped molecule that encircles DNA, with no promi- intermonomer interface of PCNA is also disordered. The
final model of 6,154 nonhydrogen protein atoms andnent crevices or grooves suggestive of high affinity bind-
ing sites for a peptide. 295 water molecules was refined to values of 28.9% and
19.2% for the free and working R values, respectively,The loading of PCNA onto DNA by the RF–C complex
does not appear to be affected appreciably by p21 using X-ray data between 7.0 and 2.6 A˚. Crystals of
human PCNA obtained in the absence of the peptide(Gibbs et al., submitted; Podust et al., 1995). Likewise,
the ability of PCNA to move along DNA is also not af- diffract poorly, and thus no structure of the uncom-
plexed form was obtained.fected by p21 (Podust et al., 1995). Consequently, p21
is likely to interfere with PCNA–dependent DNA replica-
tion by disruption of the structure of PCNA or by pre- Structure of Human PCNA
venting attachment of DNA polymerases d or e to the Human PCNA shares 35% sequence identity with
PCNA ring. scPCNA (Almendral et al., 1987; Bauer and Burgers,
We now report the crystal structure of human PCNA 1990), and its three-dimensional structure is highly simi-
complexed with a peptide corresponding to the 22 lar to the structure of the latter (Krishna et al., 1994;
C-terminal residues of p21, determined at a resolution Figure 1). A set of three molecules of PCNA, each con-
of 2.6 A˚. The structure reveals that the peptide is an- sisting of two similar domains, is assembled into a circu-
chored on PCNA via hydrogen-bonding interactions that lar ring with a central hole wide enough easily to encircle
exploit a characteristic feature of the PCNA architecture, duplex DNA (Figure 2). The structures of human and
a long interdomain connector chain that crosses back yeast PCNA are closely superimposable over the core
over the outer surface of each of the three PCNA mole- secondarystructural elements,with a root-mean-square
cules in the trimer. In addition to the formation of an deviation of 0.9 A˚ for 170 Ca positions in the monomers
antiparallel b strand structure with the connector, basic (Figure 1b). Each of the secondary structural elements
regions of the p21 peptide complement electrostatically of scPCNA is preserved in human PCNA (for notation
the markedly negative electrostatic potential of the sur- see Figure 1). Antiparallel interactions between strands
face of PCNA, and hydrophobic residues in two regions
bD2 and bI1 in adjacent PCNA subunits are the key ele-of the peptide are accommodated by hydrophobic cavit- ments in the intermolecular interface and lead to the
ies on the surface of PCNA that are likely induced by formation of a total of three nine-stranded b sheets that
peptide binding. Comparison with the structure of un- form a contiguous surface across each intermolecular
complexed scPCNA reveals that the peptide does not boundary. Likewise, antiparallel interactions between
interfere with oligomerization or with the central cavity strands bD1 and bI2 within one molecule result in thethrough which DNA is threaded. formation of three similar b sheets across the interdo-
The p21–PCNA interface has the hallmarks of a tight main boundaries within one molecule. Together, these
and specific molecular interaction, and by its ability to six curved b sheets form an outer scaffold that supports
block DNA replication it maps regions of the PCNA sur- an inner lining of 12 a helices that are oriented approxi-
face that are likely to be important for polymerase at- mately perpendicular to the ring face.
tachment. These regions on PCNA are also potential The PCNA ring has a distinct front and back. On one
targets for the design of small molecule analogs that face, a number of prominent loops connecting adjacent
might mimic the action of the p21 peptide. antiparallel b strands protrude into solvent (in partic-
ular bD2–bE2 and bH1–bI1), while on the other a long
loop (bI1–bA2, the interdomain connector loop) links theResults and Discussion
N- and C-terminal domains of each monomer. In terms
of topological elements, this connector loop providesStructure Determination
the most obvious deviation from pseudohexagonal sym-Trigonal crystals of the human PCNA–p21 peptide com-
metry, as it traverses the intrasubunit but not intersub-plex (P3221, a 5 83.5 A˚, c 5 233.9 A˚) diffract X-rays unit domain boundaries.beyond 2.6 A˚ when cryogenically cooled. However, col-
lection of data to this resolution on a conventional labo-
ratory X-ray source is problematic because of the long The Protein–Peptide Interface
A 22 residue peptide is bound to each of the three PCNAlattice spacing along the c axis; a dataset complete to
2.6 A˚ was collected at Brookhaven National Synchrotron subunits of the ring (Figures 1 and 2). Binding of the p21
peptide to PCNA involves an extensive set of interac-Light Source (Beamline X25). The crystal structure was
determined by molecular replacement, using the struc- tions spanning the entire length of the peptide and bury-
ing 2,242 A˚2 of total surface area at the intermolecularture of scPCNA as the initial model (Krishna et al., 1994).
A well-defined and continuous segment of electron den- interface (57% on the peptide, 43% on PCNA). The pep-
tide inhibitor binds in an almost fully extended confor-sity running alongside the connector loop of PCNA indi-
cated the location of the p21-peptide in initial electron mation across one face of each PCNA subunit, leaving
the hole in the middle of the ring uncovered (Figure 2).density maps. Of the 22 residues of the peptide
Crystal Structure of p21–PCNA Complex
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Figure 1. Ribbon Diagram of the PCNA Mo-
nomer with Bound p21 Peptide
(a) Stereo diagram of the three-dimensional
structure of one monomer of the PCNA–p21
peptide complex, looking directly onto the
face of the ring. The peptide (colored red)
runs alongside the interdomain connecting
loop (green). The N-terminal domain of PCNA
is drawn in yellow and the C-terminal domain
in plum, with five residues at the terminus
shaded blue. Figure prepared using the pro-
grams MOLSCRIPT (Kraulis, 1991) and Ras-
ter-3D (Bacon and Anderson, 1988).
(b) Superimposition of the Ca trace of PCNA
from S. cerevisiae (red) onto that of human
PCNA (black) with bound p21 peptide (green).
The orientation is similar to that in (a). Pre-
pared using the programs O (Jones et al.,
1991) and MOLSCRIPT (Kraulis, 1991).
It has been reported that p21 might destabilize the PCNA loop, loops bC1–bD1 and bG2–bH2, and the C-terminus
of PCNA. Finally, residues from the N-terminal portiontrimer, as assayed by glutaraldehyde cross-linking and
Western blot analysis (Chen et al., 1995a). In structural of the peptide interact with the C-terminus of the PCNA
molecule. The residues involved in the third interactionterms, the peptide does not interfere directly with oligo-
merization of PCNA; each peptide contacts only one are poorly ordered (GRKRR in p21 and IEDEEGS at the
C-terminus of PCNA). However, the relative positions ofsubunit and does not overlap the intermolecular inter-
face. Destabilization of the PCNA trimer is therefore not the residues in the structure make it clear that ion-pair-
ing interactions occur and that the disorder in the struc-likely to be a major mechanism for p21 action.
The peptide makes contacts with three distinct re- ture probably arises from the multiple possibilities for
such interactions.gions of the PCNA surface, resulting in interactions with
residues from both domains and the interdomain con-
nector. The C-terminal region of the peptide forms an Interactions between the Peptide
and the Interdomain Connectorantiparallel b sheet with the connector loop of PCNA,
resulting in seven interprotein backbone amide-to-car- The nine C-terminal residues of the peptide (152HSK
RRLIFS160) form a b strand that runs antiparallel to onebonyl hydrogen bonds. The side chains of the peptide
in this region interact with residues from the N-terminal formed by the N-terminal portion of the interdomain
connector loop (see Figure 1). Ion-pairing and hydrogen-domain of PCNA that lie under the interdomain connec-
tor. Secondly, three central residues of the peptide are bonding interactions are formed between Arg-155 and
Arg-156 of the peptide and PCNA residues Glu-124 andanchored in a hydrophobic cleft between the connector
Cell
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Figure 2. Solvent-Accessible Surface of the PCNA Trimer
(a) The peptide is shown as a stick representation, with side chains colored according to their physical properties (negatively charged residues
are drawn in red, positively charged in blue, polar in orange, and hydrophobic in yellow). An enlarged view of the peptide-binding surface is
shown in the inset. This figure was generated using GRASP (Nicholls et al., 1991).
(b) Molecular surface of the complex, with PCNA colored according to electrostatic potential and the peptide shown in white. In the calculation
of electrostatic potential, we used dielectric constants of 2.0 for the protein interior and 80 for solvent at an ionic strength equivalent to 100
mM KCl. Side chains of lysine and arginine residues were given a net positive charge and aspartate and glutamate negative, with other
residues considered neutral. Regions of intense positive charge appear blue, and electronegative regions of the surface are red.
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Gln-125 from the connector loop, and Asp-29 from provides a boundary to the exterior and is itself packed
against two proline residues (Pro-234 and Pro-253; Fig-strand bB1. A small hydrophobic pocket formed at the
junction of the connector loop and the underlying b ure 3). The hydroxyl group of Tyr-151 forms a hydrogen
bond with Gln-131 of PCNA and additionally, via ansheet of the N-terminal domain of PCNA accommodates
the side chain of Ile-158 of the peptide. The hydroxyl ordered water molecule, interacts with the hydroxyl of
Tyr-133 and the backbone carbonyl of Pro-234 (Figureof Ser-160 of the peptide participates in two hydrogen
bonds to the PCNA backbone. Ser-160 also interacts 3a). The polar side chains of Gln-144 and Thr-145 of
the peptide form hydrogen bonds with the main-chainvia the main-chain nitrogen with the carboxylate of Asp-
120 (Figure 3a). carbonyls of Ala-252 and Pro-253 at the C-terminus of
PCNA. A well-ordered water molecule bridges betweenThe observed interaction between the p21 peptide
and the interdomain connector is consistent with the the Oe of the glutamine and the amide-nitrogen atom of
Ala-208 at the C-terminal end of the bF2 strand of PCNA.results of Warbrick et al. (1995), who showed that the
connector region of PCNA is necessary for p21 binding. The hydrophobic crevice in human PCNA that binds
to Met-147 and Tyr-151 of the p21 peptide is not appar-The sequence of nine residues (152HSKRRLIFS160) is im-
portant for the inhibition of DNA replication by p21; re- ent in the structure of scPCNA and is formed by a shift
in the position of the interdomain connector loop (seelated peptides from the C-terminus of p21 that do not
include this segment lack the capacity to block replica- Figure 1b). This conformational change in human PCNA
may have been induced by peptide binding, since thetion (Warbricket al.,1995). Results of alanine scan muta-
tions reported in that study are also consistent with the structures of human and S. cerevisiae PCNA overlap
closely in all other regions (see Figure 1b). However,structure of the p21–PCNA complex. Truncation to Cb
of the side chains of Arg-155, Arg-156, Ile-158, or Ser- the amino acids in the connector loop are divergent
in sequence (only 15% sequence identity), and in the160 (mentioned earlier as interacting with PCNA resi-
dues) decreased inhibitory activity of the peptide, absence of a structure for the uncomplexed form of
human PCNA, the origin of the structural difference iswhereas truncating the side chains of His-152, Ser-153,
Leu-157, or Phe-159, which make no polar or hydropho- unclear. It is interesting to note that despite the close
overall structural similarity between the two PCNAs, thebic contacts with PCNA, does not appear to affect the
biological activity significantly (Warbrick et al., 1995). p21 peptide does not bind to scPCNA and is unable to
inhibit DNA replication carried out by S. cerevisiae PolThe connector loop of PCNAis an architectural feature
of particular interest on the exterior of an otherwise d, RF–C, and scPCNA (Gibbs et al., submitted). This
difference in binding ability can be explained by se-symmetrical molecule. It arises as a consequence of the
modular construction of the PCNA ring, in which each quence differences in the interdomain connector and
adjacent regions of the two PCNA molecules (Gibbs etsubunit comprises two topologically similar domains
that are linked in a head-to-tail fashion but where the al., submitted).
arrangement of secondary structural elements is such
that the terminal strand of the first domain does not
Electrostatic Complementarity between the p21abut the firststrand of thesecond but is located approxi-
Peptide and PCNAmately 40 A˚ away. This necessitates a very long cross-
Calculation of theelectrostatic potential of human PCNAover loop to connect the two domains (see Figure 1). As
shows that the surface of the trimer has a highly negativeit traverses the interdomain boundary, this polypeptide
potential, except in the central channel where a regionchain (PCNA residues 119–134) is involved in a number
of positive potential is created by several lysine andof interactions with residues from the surface of the
arginine side chains (see Figure 2b). This is true of allunderlying b sheet, but the hydrogen-bonding potential
known structures of sliding clamps, and the positiveof the backbone of the connector loop is not utilized
charge in the central region is thought to be importantand is available for interaction with othermolecules such
in stabilizing the PCNA trimer on the negatively chargedas p21.
phosphate backbone of DNA (Fukuda et al., 1995;
Krishna et al., 1994). It has been noted that the C-termi-
nal region of p21 contains a classical bipartite nuclearHydrophobic Interactions
The eight–amino acid motif (144QTSMTDFY151) in the cen- localization signal, in which two basic regions are sepa-
rated by about 10 residues, some of which are hy-tral part of the p21 peptide is required for binding to
PCNA; in particular, Met-147 and Phe-150 of p21 are drophobic (El-Deiry et al., 1993; Robbins et al., 1991).
The two basic regions of the peptide complement elec-critical for recognition of PCNA (Nakanishi et al., 1995;
Warbrick et al., 1995). In the structure of the complex, trostatically the negatively charged surface of PCNA. A
total of seven positively charged groupson each peptideresidues (146SMTDFY151) adopt a 310 helical conformation,
stabilized by an intramolecular hydrogen-bonding net- interact with a similar number of negatively charged
groups on each monomer of PCNA, including the car-work in which the carboxyl moiety of Asp-149 accepts
hydrogen bonds from both the amide nitrogen atom of boxyl group at the C-terminus.
The N-terminal basic residues of the peptide (139GRThr-145 and the side-chain hydroxyl of Ser-146, while
the Og of Thr-148 of p21 interacts with the hydroxyl of KRR143) are not visualized in the electron density maps,
but it appears that they interact with the highly acidicthis same serine residue. This configuration positions
both Met-147 and Tyr-151 of p21 in a hydrophobic cavity C-terminal tail of PCNA (256EDEEGS261). Residues Lys-
254 and Ile-255 of PCNA and residues Arg-143, Gln-under the connector loop of PCNA. The Phe-150 side
chain of the peptide does not enter this cleft but rather 144, and Thr-145 of p21 are arrayed antiparallel to each
Cell
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Figure 3. Interactions at the p21–PCNA Interface
(a) Schematic depiction of contacts between the peptide and PCNA. Residues of the connector loop of PCNA are shaded green, those of
the C-terminus are in yellow, and other PCNA residues are in pink. A set of two water-mediated contacts is also shown (blue circles).
(b) Hydrophobic interactions at the p21–PCNA interface. A set of four side chains of the p21-peptide (red) fit into hydrophobic cavities in the
molecular surface of PCNA. The Ca trace of PCNA is displayed as a green tube. PCNA residues lining the pockets (shown in yellow) are: Cys-
27, Met-40, Val-45, Leu-47, Ala-67, Gly-69, Leu-121, Val-123, Leu-126, Ile-128, Pro-129, 133-Tyr, Pro-234, Tyr-250, Ala-252, Pro-253, and (in
green) Gln-131, which contacts the hydroxyl of the peptide tyrosine. This figure was generated using GRASP.
(Figure 3 continued on next page)
other. Although the model cannot be extended beyond Conclusion
High processivity during chromosomal replication is fa-these residues unambiguously, the spatial disposition
of the two peptide chains suggests that the remaining cilitated by the attachment of the catalytic subunits
(DNA polymerase and exonuclease) to a sliding-clampfour N-terminal residues of p21 and the six C-terminal
residues of PCNA are associated closely. protein that encircles the DNA, enabling the polymerase
Crystal Structure of p21–PCNA Complex
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to move rapidly along DNA without dissociation from Hall et al., 1995; Matsuoka et al., 1994). A more detailed
the template. The close similarity in the architectures comparison with the binding mode of p21 is not yet
of PCNA and the b subunit of Escherichia coli DNA possible because of a lack of sequence similarity be-
polymerase III showed that this basic mechanism of tween these proteins and owing to the coarse resolution
processive DNA replication was conserved between of the deletion analysis.
prokaryotic and eukaryotic systems (Kong et al., 1992; Comparison of the structure of the p21–PCNA com-
Krishna et al., 1994). Recent evidence indicates that p21 plex with that of the p27Kip1–cyclin–cdk complex (Russo
blocks PCNA–dependent DNA replication by preventing et al., 1996) shows that p21 will be able to bind both its
chain elongation rather than by affecting RFC–catalyzed targets simultaneously, consistent with the observation
clamp loading (Gibbs et al., submitted; Podust et al., that in normal eukaryotic cellsPCNA is found in complex
1995). The structure of the inactive p21–PCNA complex with cyclin–cdk and p21 (Xiong et al., 1993). The region
shows that p21 binds tightly but with minimal perturba- of p21 that interacts with PCNA has been shown to be
tion to the PCNA structure. The major elements of PCNA unstructured in isolation (Chen et al., 1996), as has the
that are engaged by the p21 peptide (the interdomain region of p27Kip1 that binds to cyclin–cdk (Russo et al.,
connector and the C-terminal tail) are conserved, in ar- 1996). The p21 inhibitor can therefore be thought of as
chitectural terms, in the E. coli b subunit structure. This a molecular grappling hook that has flexible and extensi-
suggests that the p21–PCNA interaction represents the ble ends which become structured and tightly attached
jamming of an interfacial region that is fundamental to upon recognition of the proper targets.
the interaction with the polymerase subunit. Consistent
with this, an antibody whose epitope spans the connec-
Experimental Procedurestor loop of human PCNA (residues 121–135) efficiently
inhibits DNA replication in vitro (Roos et al., 1996). Muta-
Crystallographic Datation of Asp-122 to Ala in the connector loop of human
Recombinant human PCNA (Almendral et al., 1987) was expressed
PCNA affects Pol d stimulation by PCNA but not the in E. coli and purified as described previously (Kelman, 1996). Briefly,
interaction with RF–C (Fukuda et al., 1995). E. coli strain BL21 (DE3) pLysS was used to express human PCNA,
In addition to the interaction with p21 described here, which was purified by standard methodologies, using chromatogra-
phy on Q Sepharose Fast Flow and Heparin Sepharose (Pharmacia).PCNA has been shown to interact directly with cyclin D
The protein was extensively dialyzed against 20 mM Tris–HCl (pH(Matsuoka et al., 1994) and with the cell cycle–depen-
7.5), 2 mM dithiothreitol, 0.5 mM EDTA, and 10% glycerol (no salt)dent protein Gadd45 that is also induced by DNA dam-
and concentrated. A 1.5-fold molar excess of synthetic p21 peptide
age (Smith et al., 1994). In both cases, mapping of the (139GRKRRQTSMTDFYHSKRRLIFS160) was incubated with human
interaction region by deletion mutagenesis indicates PCNA (20 mg/ml). The complex that formed was used to screen for
that the interface with PCNA is extensive, including resi- crystallization conditions using the hanging-drop vapor diffusion
method and revealed a number of conditions for crystal growth. Ofdues from both domains of PCNA (Chen et al., 1995a;
Cell
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Figure 4. p21 Peptide Binding Site on PCNA
(a) Difference electron density for the p21-
peptide. To calculate the electron density
map, we deleted residues of one peptide and
subjected the remaining atoms to refinement
using a simulated annealing protocol (Bru¨n-
ger et al., 1990). The resulting coordinates
were used to generate structure factor ampli-
tudes and phases for a Fourier synthesis. The
peptide is shown with the carbon atoms col-
ored white.
(b) Electron density for the peptide and PCNA
connector loop is clearly evident in a 3-fold
averaged 2|Fo|-|Fc| map (15.0–3.0 A˚; con-
toured at 1.5 s) calculated from the molecular
replacement solution prior to any rebuilding
or positional refinement of the model.
these, two crystal forms diffracted X-rays strongly enough to enable imaging plate system on Beamline X25 at Brookhaven National Syn-
chrotron Light Source. All images wereprocessed using the programdata collection.
To obtain crystal form I, 1 ml of the complex was mixed with 0.5 DENZO, and the integrated intensities were scaled and merged with
SCALEPACK (Z. Otwinowski and W. Minor, unpublished data). A setml of 1 M spermine and 1 ml of a reservoir solution containing 100
mM sodium citrate (pH 5.6), 30% (v/v) 2,5-methylpentanediol (MPD), of 130,418 structure factors (33,552 unique) were measured in the
resolution range 15.0–2.6 A˚, resulting in a dataset that is 96% com-and 200 mM sodium/potassium phosphate. Crystals grown at 48C
under these conditions are trigonal (point group 32, a 5 83.5 A˚, c 5 plete (96.4% in the outer shell). The overall agreement factor, Rmerge
(on intensity), is 7.3% (27.8% in the outer shell).233.9 A˚) with one PCNA trimer in the asymmetric unit and diffract
to around 2.6 A˚ on a conventional X-ray source.
Crystal form II grows at 48C from 100 mM MES (pH 6.0), 30% (v/v) Structure Solution and Refinement
The PCNA structure was solved by the molecular replacementMPD, and 200 mM magnesium acetate (space group P3; a 5 143.2 A˚,
c 5 41.4 A˚). Although this crystal form diffracts X-rays strongly to method using XPLOR (Bru¨nger, 1992). A partially refined model of
the human PCNA monomer previously derived from Form II crystalsBragg spacings of 2.0 A˚, it is characterized by perfect hemihedral
twinning, and diffraction from the crystals is consistent with the was used to initiate rotation and translation searches in the resolu-
tion range 8.0–4.0 A˚. A peak 6.7 s above the mean was the highestLaue group 6/m. Using this crystal form, a model for PCNA and part
of the peptide was built based on a molecular replacement solution in the rotation function. Translation searches using the entire PCNA
trimer to enhance signal were calculated in the enantiomorphicin which scPCNA was utilized as a search model; the data were
detwinned according to the procedure of Redinbo and Yeates space groups P3221 and p3121, in each case finding a peak well
above the mean (9.6 s and 9.4 s, respectively). A set of 30 cycles(1993). Refinement of this model proved unsatisfactory and was not
pursued. Structure determination therefore proceeded using crystal of rigid-body refinement of the positioned trimer reduced the R value
to 40% in both space groups, using data between 8.0 and 4.0 A˚.form I.
Crystals of form I were initially transferred into reservoir solution The distinction between the two space groups is subtle, since the
noncrystallographic 3-fold symmetry of each PCNA ring in combina-containing an increased concentration of MPD (35%). They were
then mounted in nylon loops with the longest cell axis approximately tion with the 3-fold crystallographic screw-axes results in very simi-
lar molecular packing in either case. Refinement proceeded satis-colinear with the spindle and flash-frozen at 100 K. Data to 2.6 A˚
resolution were collected from a single crystal using a 30 cm MAR factorily to completion in P3221. Merohedral twinning as seen in
Crystal Structure of p21–PCNA Complex
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form II crystals was ruled out in this case on the basis of intensity Bauer, G.A., and Burgers, P.M. (1990). Molecular cloning, structure
and expression of the yeast proliferating cell nuclear antigen gene.statistics (Redinbo and Yeates, 1993) and by the presence of strong
electron density for the peptide in positions related by a 3-fold axis Nucl. Acids Res. 18, 261–265.
of symmetry (in the twinned crystal form, weak density correspond- Bru¨nger, A.T. (1992). XPLOR Version 3.1: A System for X-Ray Crystal-
ing to the peptide appears on a physically meaningless 6-fold axis). lography and NMR (New Haven, Connecticut: Yale University).
For the refinement of the structure, all temperature factors were
Bru¨nger, A.T., Krukowski, A., and Erickson, J.W. (1990). Slow-cool-fixed at 20 A˚2, and the entire connector loop and several residues
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